Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents

Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents

Abstract Background The purpose of this study was to investigate retinal layers changes in patients with age-related macular degeneration (AMD) treated with anti-vascular endothelial growth factor (anti-VEGF) agents and to evaluate if these changes may affect treatment response. Methods This study i...

Full description

Bibliographic Details
Main Authors:	Dan Zhou, Yan Hu, Zhongxi Qiu, Zirong Liu, Hongyang Jiang, Ryo Kawasaki, Jiang Liu
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	BMC Ophthalmology
Subjects:	AMD PCV Anti-VEGF OCT Retinal layers Treatment response
Online Access:	https://doi.org/10.1186/s12886-023-03203-w

Similar Items

Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
by: Radina Kirkova, et al.
Published: (2022-09-01)

Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
by: Joel Hanhart, et al.
Published: (2017-10-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
by: Deepali R Damkondwar, et al.
Published: (2022-01-01)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
by: Cui C, et al.
Published: (2017-12-01)

Impact of Delayed Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Due to the Coronavirus Disease Pandemic on the Prognosis of Patients with Neovascular Age-Related Macular Degeneration
by: Jae-Gon Kim, et al.
Published: (2022-04-01)

Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration: Case Series
by: Filomena Palmieri, et al.
Published: (2023-03-01)

Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
by: Cvetkova NP, et al.
Published: (2016-06-01)

Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
by: Bek T, et al.
Published: (2018-03-01)

Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes
by: Małgorzata Wichrowska, et al.
Published: (2022-12-01)

Abnormalities in the thickness of the retinal ganglion cell/inner plexiform layer in age-related macular degeneration
by: Živković Maja, et al.
Published: (2020-01-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
by: Avaylon J, et al.
Published: (2020-05-01)

Machine learning and optical coherence tomography-derived radiomics analysis to predict persistent diabetic macular edema in patients undergoing anti-VEGF intravitreal therapy
by: Zhishang Meng, et al.
Published: (2024-04-01)

Findings of uncertain significance by optical coherence tomography (OCT) as prognostic factors in neovascular age-related macular degeneration (nAMD) treated with ranibizumab
by: Ricardo Hayashi-Mercado, et al.
Published: (2022-04-01)

Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration
by: Joseph B. Lin, BS, et al.
Published: (2024-03-01)

Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients
by: Jin-Ho Joo, et al.
Published: (2021-11-01)

Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
by: Paolo Corazza, et al.
Published: (2021-08-01)

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy
by: Thomas Bertelmann, et al.
Published: (2017-04-01)

Retinal angiomatous proliferation and polypoidal choroidal vasculopathy – phenotypes of neovascularisation in age-related macular degeneration
by: Tomislav Šarenac, et al.
Published: (2016-12-01)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
by: Maria Cristina Savastano, et al.
Published: (2021-10-01)

The Safety of Anti-VEGF Treatment, in the Context of the Retinal Nerve Fibre Layer, in Patients with Wet Age-Related Macular Degeneration: A Review
by: Małgorzata Wichrowska, et al.
Published: (2023-09-01)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
by: Praveen Yerramothu
Published: (2018-07-01)

Comparison of short-time efficacy of anti-VEGF therapy or anti-inflammatory therapy on different types of macular edema secondary to retinal vein occlusion
by: Xue-Fei Ding, et al.
Published: (2022-03-01)

Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration
by: Tobias Strunz, et al.
Published: (2022-05-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
by: Reem H. ElSheikh, et al.
Published: (2022-11-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
by: Ngoc Thien Le, et al.
Published: (2023-12-01)

Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
by: Miklós D. Resch, et al.
Published: (2022-12-01)

Choroidal Vascular Impairment in Intermediate Age-Related Macular Degeneration
by: Rita Flores, et al.
Published: (2022-05-01)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
by: Koike N, et al.
Published: (2019-07-01)

Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure:a comparative clinical study
by: Gökhan Özge, et al.
Published: (2013-04-01)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
by: Tan CS, et al.
Published: (2022-03-01)

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration
by: Nadia Zakaria, et al.
Published: (2022-04-01)

Choroidal Neovascular Membrane in Age-Related Macular Degeneration is Associated with Increased Interleukin-6
by: Zuhal Yildirim, et al.
Published: (2012-06-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
by: Ines Lains, MD, PhD, et al.
Published: (2024-01-01)

Bilateral Hypertensive Retinopathy Complicated with Retinal Neovascularization: Panretinal Photocoagulation or Intravitreal Anti-VEGF Treatment
by: Odysseas Georgiadis, et al.
Published: (2014-07-01)

Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment
by: Yupeng Xu, et al.
Published: (2019-05-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
by: Rita Flores, et al.
Published: (2021-12-01)

Microglia Contribution to the Regulation of the Retinal and Choroidal Vasculature in Age-Related Macular Degeneration
by: C. Henrique Alves, et al.
Published: (2020-05-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01)

Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
by: Shinichiro Chujo, et al.
Published: (2023-05-01)

Microvascular comparison in younger and older patients with retinal vein occlusion analyzed by OCT angiography
by: Panpan Ye, et al.
Published: (2021-04-01)